313
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer

ORCID Icon, , , , , ORCID Icon & show all
Pages 997-1015 | Received 10 Jan 2023, Accepted 28 Feb 2023, Published online: 21 Mar 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17(3):362–387. doi:10.1016/j.jtho.2021.11.003
  • Deb D, Moore AC, Roy UB. The 2021 global lung cancer therapy landscape. J Thorac Oncol. 2022;17(7):931–936. doi:10.1016/j.jtho.2022.03.018
  • Pala L, Sala I, Oriecuia C, et al. Association of anticancer immune checkpoint inhibitors with patient-reported outcomes assessed in randomized clinical trials: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(8):e2226252. doi:10.1001/jamanetworkopen.2022.26252
  • Xiong A, Wang J, Zhou C. Immunotherapy in the first-line treatment of NSCLC: current status and future directions in China. Front Oncol. 2021;11:757993. doi:10.3389/fonc.2021.757993
  • Bote H, Mesas A, Baena J, Herrera M, Paz-Ares L. Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer. Expert Opin Emerg Drugs. 2022;27(3):289–300. doi:10.1080/14728214.2022.2113377
  • Wang C, Yu Q, Song T, et al. The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing. Signal Transduct Target Ther. 2022;7(1):289. doi:10.1038/s41392-022-01130-8
  • Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381–396. doi:10.1038/s41568-022-00459-0
  • Dierge E, Debock E, Guilbaud C, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021;33(8):1701–1715.e5. doi:10.1016/j.cmet.2021.05.016
  • Zou Y, Henry WS, Ricq EL, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585(7826):603–608. doi:10.1038/s41586-020-2732-8
  • Kim R, Hashimoto A, Markosyan N, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612(7939):338–346. doi:10.1038/s41586-022-05443-0
  • Ye H, Adane B, Khan N, et al. Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells. Cancer Cell. 2018;34(4):659–673.e6. doi:10.1016/j.ccell.2018.08.016
  • Xu T, Gao S, Liu J, Huang Y, Chen K, Zhang X. MMP9 and IGFBP1 regulate tumor immune and drive tumor progression in clear cell renal cell carcinoma. J Cancer. 2021;12(8):2243–2257. doi:10.7150/jca.48664
  • Liu M, Yan W, Chen D, et al. hiWNT3Alo subtype in esophageal cancer predicts response and prolonged survival with PD-(L)1 inhibitor. Biology. 2022;11(11):1575. doi:10.3390/biology11111575
  • Li Y, Gao Y, Chu W, Lv J, Li Z, Shi T. Differences in and verification of genetic alterations in chemotherapy and immunotherapy for metastatic melanoma. Aging. 2021;13(20):23672–23688. doi:10.18632/aging.203640
  • Nagy Á, Győrffy B. muTarget: a platform linking gene expression changes and mutation status in solid tumors. Int J Cancer. 2021;148(2):502–511. doi:10.1002/ijc.33283
  • Chandrashekar DS, Karthikeyan SK, Korla PK, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27. doi:10.1016/j.neo.2022.01.001
  • Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
  • Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–D612. doi:10.1093/nar/gkaa1074
  • Zhou N, Yuan X, Du Q, et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2023;51(D1):D571–D582. doi:10.1093/nar/gkac935
  • Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514. doi:10.1093/nar/gkaa407
  • Dempster JM, Boyle I, Vazquez F, et al. Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects. Genome Biol. 2021;22(1):343. doi:10.1186/s13059-021-02540-7
  • Brouwer AF, Engle JM, Jeon J, Meza R. Sociodemographic survival disparities for lung cancer in the United States, 2000–2016. J Natl Cancer Inst. 2022;114(11):1492–1500. doi:10.1093/jnci/djac144
  • Chen P, Liu Y, Wen Y, Zhou C. Non-small cell lung cancer in China. Cancer Commun. 2022;42(10):937–970. doi:10.1002/cac2.12359
  • Ramos-Esquivel A. Immunotherapy in non-small-cell lung cancer: new data support its use, but some challenges remain. Thorax. 2022;77(12):1159–1160. doi:10.1136/thorax-2022-219472
  • Kashefizadeh A, Kazemizadeh H. Immunogenic cell death (ICD)-inducers in non-small-cell lung carcinoma (NSCLC): current knowledge and future perspective. Clin Transl Oncol. 2022;25(2):316–322. doi:10.1007/s12094-022-02949-x
  • Oliva M, Demanelis K, Lu Y, et al. DNA methylation QTL mapping across diverse human tissues provides molecular links between genetic variation and complex traits. Nat Genet. 2023;55(1):112–122. doi:10.1038/s41588-022-01248-z
  • Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi:10.1038/nature25183
  • Hellyer JA, Padda SK, Diehn M, Wakelee HA. Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLC. J Thorac Oncol. 2021;16(3):395–403. doi:10.1016/j.jtho.2020.11.015
  • Ma F, Laster K, Dong Z. The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations. Nat Commun. 2022;13(1):5651. doi:10.1038/s41467-022-33351-4
  • Cascone T, Fradette J, Pradhan M, Gibbons DL. Tumor immunology and immunotherapy of non-small-cell lung cancer. Cold Spring Harb Perspect Med. 2022;12(5):a037895. doi:10.1101/cshperspect.a037895
  • Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020;20(9):485–503. doi:10.1038/s41568-020-0281-y
  • Salcher S, Sturm G, Horvath L, et al. High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer. Cancer Cell. 2022;40(12):1503–1520.e8. doi:10.1016/j.ccell.2022.10.008
  • Zahid KR, Raza U, Tumbath S, Jiang L, Xu W, Huang X. Neutrophils: musketeers against immunotherapy. Front Oncol. 2022;12:975981. doi:10.3389/fonc.2022.975981
  • Teijeira A, Garasa S, Ochoa MC, et al. IL8, neutrophils, and NETs in a collusion against cancer immunity and immunotherapy. Clin Cancer Res. 2021;27(9):2383–2393. doi:10.1158/1078-0432.CCR-20-1319
  • Cui C, Chakraborty K, Tang XA, et al. Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell. 2021;184(12):3163–3177.e21. doi:10.1016/j.cell.2021.04.016
  • Brandt K, Lundell K, Brismar K. Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, −2 and −4. Growth Horm IGF Res. 2011;21(3):167–173. doi:10.1016/j.ghir.2011.04.003
  • Mair F, Erickson JR, Frutoso M, et al. Extricating human tumour immune alterations from tissue inflammation. Nature. 2022;605(7911):728–735. doi:10.1038/s41586-022-04718-w
  • Zhang C, Tang B, Hu J, et al. Neutrophils correlate with hypoxia microenvironment and promote progression of non-small-cell lung cancer. Bioengineered. 2021;12(1):8872–8884. doi:10.1080/21655979.2021.1987820
  • Mu T, Li H, Li X. Prognostic implication of energy metabolism-related gene signatures in lung adenocarcinoma. Front Oncol. 2022;12:867470. doi:10.3389/fonc.2022.867470
  • Li F, Cao Y, Li J, et al. The clinical significance of serum adipocytokines level in patients with lung cancer. J Thorac Dis. 2019;11(8):3547–3555. doi:10.21037/jtd.2019.07.66
  • Dowery R, Benhamou D, Benchetrit E, et al. Peripheral B cells repress B-cell regeneration in aging through a TNF-α/IGFBP-1/IGF-1 immune-endocrine axis. Blood. 2021;138(19):1817–1829. doi:10.1182/blood.2021012428
  • Wiernicki B, Maschalidi S, Pinney J, et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun. 2022;13(1):3676. doi:10.1038/s41467-022-31218-2
  • Sharma V, Varshney R, Sethy NK. Human adaptation to high altitude: a review of convergence between genomic and proteomic signatures. Hum Genomics. 2022;16(1):21. doi:10.1186/s40246-022-00395-y